CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity

Clinical Pharmacology and Therapeutics
Elena García-MartínJosé A G Agúndez

Abstract

Our objective was to evaluate the presence of CYP3A4 gene variants in white individuals with low CYP3A4 enzyme activity. Persons with extremely low enzyme activity, either in vitro or in vivo, were selected in a panel of 97 healthy subjects. Genetic analyses for CYP3A4 variant alleles present in white subjects, including CYP3A4*1B, CYP3A4*2, CYP3A4*4, CYP3A4*5, CYP3A4*6, CYP3A4*8, CYP3A4*11, CYP3A4*12, and CYP3A4*13, were performed on genomic deoxyribonucleic acid from these subjects by amplification-restriction and sequencing. With the exception of CYP3A4*1B, none of the variant alleles analyzed were present in 30 genes from persons with extremely low enzyme activity. CYP3A4*1B was present in the population studied with an allele frequency of 5.5%. Nevertheless, the presence of CYP3A4*1B does not correlate with low enzyme activity, either in vivo or in vitro, in either heterozygosity or homozygosity. CYP3A4*2 was not identified in 290 genes from Spanish persons or in 70 genes from Finnish persons. Although the genetic component of the interindividual variability of CYP3A4 enzyme activity seems to be high, our findings do not support a key role for the variant alleles analyzed on the majority of white persons with low CYP3A4 ac...Continue Reading

Citations

Jun 10, 2009·The Pharmacogenomics Journal·J MiaoS D Hall
Mar 28, 2008·BMC Medical Genetics·Elena García-MartínJosé Ag Agúndez
Oct 29, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Isa CavacoVera Ribeiro
Aug 12, 2009·Pharmacogenomics·Sukhwinder S LakhmanGene D Morse
Jun 23, 2011·Pharmacogenomics·Krisztina HagymásiZsolt Tulassay
Jan 11, 2014·World Journal of Gastroenterology : WJG·Alessio ProvenzaniNatale D'Alessandro
Mar 14, 2013·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Abdulkareem AlbekairyJanet Karlix
May 9, 2014·Genetics in Medicine : Official Journal of the American College of Medical Genetics·William J CanestaroKenneth E Thummel
Jun 7, 2006·Pharmacogenomics·Ji-Yeob ChoiChristine B Ambrosone
Jul 20, 2007·Pharmacogenomics·Helen Steed, Michael B Sawyer
May 1, 2007·Pharmacogenomics·Markus SchirmerLeszek Wojnowski
Sep 14, 2014·Journal of Analytical Toxicology·Lauren L Richards-WaughGary O Rankin
Jul 27, 2006·Expert Opinion on Drug Metabolism & Toxicology·Leszek Wojnowski, Landry K Kamdem
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Apr 10, 2013·Expert Opinion on Drug Metabolism & Toxicology·José A G AgúndezFélix Javier Jiménez-Jiménez
Dec 9, 2009·Expert Opinion on Drug Metabolism & Toxicology·Minoli A Perera
Aug 2, 2013·Expert Opinion on Drug Metabolism & Toxicology·Elena García-MartínJosé A G Agúndez
May 19, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Iain A M MacPheeDavid W Holt
Nov 6, 2014·Molecular Medicine Reports·Mohamad H DarwishHassan R Dhaini
Jun 14, 2014·Clinical Pharmacology and Therapeutics·A N Werk, I Cascorbi
Sep 18, 2016·The International Journal of Neuropsychopharmacology·Katalin TóthKatalin Monostory
Mar 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M RudinMark J Ratain
Jul 2, 2004·Therapeutic Drug Monitoring·Leszek Wojnowski
Oct 29, 2012·Journal of Personalized Medicine·Danxin Wang, Wolfgang Sadee
Sep 3, 2004·Journal of Clinical Pharmacology·Kiman KimHartmut Derendorf
Sep 3, 2011·Pharmacogenetics and Genomics·Juan Gonzalo RestrepoJosé A G Agúndez
Dec 7, 2018·Pharmacogenomics·Teresa T HoAmarilis Sanchez-Valle
Oct 2, 2004·Human Molecular Genetics·Takeshi HirotaKenji Otsubo
Mar 17, 2007·Bulletin of Experimental Biology and Medicine·E G ShchepotinaV V Lyakhovich
Apr 4, 2008·European Journal of Clinical Pharmacology·Kyoung-Ah KimJi-Young Park
May 19, 2005·Pharmacogenetics and Genomics·Russell A WilkeJames K Burmester
Dec 14, 2005·Pharmacogenetics and Genomics·Markus SchirmerL Wojnowski
Jul 9, 2010·Allergy·G GervasiniE García-Martín
Nov 22, 2005·Expert Opinion on Drug Delivery·Suresh KatragaddaAshim K Mitra
Nov 4, 2005·Investigational New Drugs·Ron H N van Schaik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.